Skip to content

ENhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive surveillaNCe With Duplex and Endovascular Treatment

ENhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive surveillaNCe With Duplex and Endovascular Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01597115
Acronym
ENHANCE
Enrollment
150
Registered
2012-05-11
Start date
2012-05-31
Completion date
2014-09-30
Last updated
2015-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease

Keywords

duplex study, hemodialysis access, maturation rate, endovascular intervention

Brief summary

The aim of this study is to evaluate whether Aggressive duplex surveillance after vascular access surgery with native vein for hemodialysis can increase the maturation rate of arteriovenous fistula. This study will be conducted as a single center, prospective, 1:1 randomized study. Enrolled patients will be randomized as a control group (Physical exam at 2 and 4 weeks after surgery) and duplex group (duplex study and physical exam at 2 and 4 weeks after surgery). Maturation of arteriovenous fistula will be evaluated at 8 weeks after surgery by duplex in all patients.

Interventions

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* end stage renal disease * newly formed hemodialysis access with native vein * 20\ 70 years

Exclusion criteria

* hemodialysis access surgery with ePTFE graft * hemodialysis access surgery with basilic vein transposition * hemodialysis access surgery with brachial vein transposition * cephalic vein \< 2.5mm in diameter * radial artery diameter \<2.0mm in radiocephalic arteriovenous fistula

Design outcomes

Primary

MeasureTime frame
hemodialysis access maturation rate8 weeks after surgery

Secondary

MeasureTime frame
factors predicting maturation failure8 weeks after surgery

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026